Cargando…

Correction: Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269452/ http://dx.doi.org/10.1371/journal.pone.0116242

Ejemplares similares

Cell-Permeable Parkin Proteins Suppress Parkinson Disease-Associated Phenotypes in Cultured Cells and Animals
por: Duong, Tam, et al.
Publicado: (2014)

Correction: Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease
Publicado: (2015)

Correction to: Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson's disease
Publicado: (2023)

Correction: Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
por: Xiao, Bin, et al.
Publicado: (2018)

Parkinson’s disease-associated protein Parkin: an unusual player in cancer
por: Liu, Juan, et al.
Publicado: (2018)

Correction: Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase
Publicado: (2014)

Correction: Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration
por: Zhang, Zengjie, et al.
Publicado: (2021)

Behavioral Phenotyping of Parkin-Deficient Mice: Looking for Early Preclinical Features of Parkinson's Disease
por: Rial, Daniel, et al.
Publicado: (2014)

The Roles of PINK1 and Parkin in Parkinson's Disease
por: Jones, Rachel
Publicado: (2010)

Correction: Metabolomics and In-Silico Analysis Reveal Critical Energy Deregulations in Animal Models of Parkinson’s Disease
Publicado: (2014)

Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
por: Gaweda-Walerych, Katarzyna, et al.
Publicado: (2021)

Publisher Correction: Parkin-dependent regulation of the MCU complex component MICU1
por: Matteucci, Alessandra, et al.
Publicado: (2019)

Correction: A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2010)

Correction: Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype
por: Hommel, Benjamin, et al.
Publicado: (2019)

Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011)

Will Crystal Parkin Help in Understanding the Future of Parkinson’s Disease?
por: Olszewska, Diana Angelika, et al.
Publicado: (2015)

Olfaction in Parkin carriers in Chinese patients with Parkinson disease
por: Wang, Ying, et al.
Publicado: (2017)

Correction: Podocalyxin Regulates Murine Lung Vascular Permeability by Altering Endothelial Cell Adhesion
Publicado: (2014)

Correction: Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment
por: Sieh, Shirly, et al.
Publicado: (2013)

Correction: Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity
por: Ghirardini, Elsa, et al.
Publicado: (2020)

Correction to ‘The emergence of collective knowledge and cumulative culture in animals, humans and machines’
por: Whiten, Andrew, et al.
Publicado: (2022)

Correction: Matrix Metalloproteinase-2 and -9 Secreted by Leukemic Cells Increase the Permeability of Blood-Brain Barrier by Disrupting Tight Junction Proteins
por: Feng, Saran, et al.
Publicado: (2011)

Short-term temporal memory in idiopathic and Parkin-associated Parkinson’s disease
por: Degos, Bertrand, et al.
Publicado: (2018)

Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
por: Obara, Yutaro, et al.
Publicado: (2017)

Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD)
por: Zhou, Zhi Dong, et al.
Publicado: (2016)

parkin counteracts symptoms in a Drosophila model of Parkinson's disease
por: Haywood, Annika FM, et al.
Publicado: (2004)

Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
por: Kamienieva, Iryna, et al.
Publicado: (2021)

Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
por: Checler, Frédéric, et al.
Publicado: (2022)

Is PARKIN parkinsonism a cancer predisposition syndrome?
por: Schüle, Birgitt, et al.
Publicado: (2015)

Correction to: Mesenchymal stem cells decrease blood–brain barrier permeability in rats with severe acute pancreatitis
por: Lin, Ronggui, et al.
Publicado: (2019)

Correction: Protein Clusters on the T Cell Surface May Suppress Spurious Early Signaling Events
por: Chung, Woo, et al.
Publicado: (2012)

Correction: Clinical Factors Associated with Abnormal Postures in Parkinson's Disease
por: Oeda, Tomoko, et al.
Publicado: (2013)

Author Correction: The role of oxygen-permeable ionomer for polymer electrolyte fuel cells
por: Jinnouchi, Ryosuke, et al.
Publicado: (2023)

Correction: Zhang et al. Parkin, as a Regulator, Participates in Arsenic Trioxide-Triggered Mitophagy in HeLa Cells. Curr. Issues Mol. Biol. 2022, 44, 2759–2771
por: Zhang, Zhewen, et al.
Publicado: (2023)

Author Correction: Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson’s disease phenotypes
por: Riboldi, Giulietta Maria, et al.
Publicado: (2023)

Correction to: Critical role of mitogen-inducible gene 6 in restraining endothelial cell permeability to maintain vascular homeostasis
por: Xing, Liying, et al.
Publicado: (2022)

A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
por: Spratt, Donald E., et al.
Publicado: (2013)

The Parkinson’s disease genes Fbxo7 and Parkin interact to mediate mitophagy
por: Burchell, Victoria S, et al.
Publicado: (2013)

Quality of Life in Newly Diagnosed Patients With Parkin-Related Parkinson's Disease
por: Zhou, Xin-Yue, et al.
Publicado: (2020)

Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease
por: Blagov, Alexander V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0uodma3bi59eoin0jo302m4i2c